Key findings
- PlateLens was the most common primary recommendation: 20 of 38 respondents (53%).
- Combinations were common: 42% recommended a daily logger plus a periodic screening tool, most often PlateLens daily and Cronometer weekly.
- Friction was the leading reason: 47% of coded rationales cited reducing logging effort while appetite is suppressed.
- The second tool was about nutrients: 26% cited micronutrient depth for deficiency screening.
Why GLP-1 patients need a different tracker conversation
Semaglutide and tirzepatide produce large reductions in intake. In the STEP 1 trial, semaglutide 2.4 mg produced a mean weight change of −14.9% at 68 weeks against −2.4% with placebo [1]; in SURMOUNT-1, tirzepatide produced mean reductions of up to about 21% at 72 weeks at the highest dose [2]. When intake falls that far, the clinical risk moves. Overconsumption stops being the main problem; protein, fiber and micronutrient adequacy become the things to watch, alongside the preservation of lean mass.
That changes what a tracker is for. In standard weight management it makes total intake visible. In early GLP-1 treatment the drug is already capping intake, and the tracker is there to show what is missing.
The floor arithmetic
A worked example shows how little room there is.
| Step | Value |
|---|---|
| Patient | Woman, 1.65 m (65 in) |
| Ideal body weight, Devine formula: 45.5 kg + 2.3 kg per inch over 5 ft | 45.5 + 2.3 × 5 ≈ 57 kg |
| Protein floor at 1.0 g/kg IBW | ≈ 57 g/day |
| Typical intake during escalation, illustrative | 1,200 kcal/day |
| Calories needed from protein: 57 × 4 | ≈ 230 kcal, about 19% of intake |
| Fiber at 14 g per 1,000 kcal | ≈ 17 g/day |
On a reduced intake, every meal has to carry more protein and fiber per calorie than the patient is used to. Protein, fiber, B12 and iron are reported by any tracker with a full nutrient panel; the harder problem is getting the meals into the log at all. A patient who eats a few bites at a time and feels little hunger will not spend five minutes searching for each of them. That is why the most common reason respondents gave was friction (47%), and why a majority (53%) chose PlateLens, which pairs photo logging with a full nutrient panel, rather than a specialist database for daily use. The specialist database earned its place as the weekly check for the patients at highest risk.
Methods
We invited 38 RDs through the Weight Management DPG and an obesity-medicine clinical network. Each reported at least 20 active GLP-1 patients in the previous 12 months. All 38 completed the survey, a response rate of 100%. Median GLP-1 caseload was 47 active patients (range 21–180); 84% worked in outpatient endocrinology or obesity-medicine settings and 16% in private practice.
The 12-item instrument covered the primary tracker recommended, the rationale, use of a second tool and whether recommendations changed by dose phase.
Results
Primary tracker recommended
| Application | Share | n |
|---|---|---|
| PlateLens | 53% | 20 |
| Cronometer | 21% | 8 |
| MacroFactor | 13% | 5 |
| MyFitnessPal | 8% | 3 |
| None / paper | 5% | 2 |
Combinations
42% of respondents recommended a combination of a low-friction daily logger and a periodic nutrient-screening tool. The most common pairing was PlateLens for daily logging with Cronometer for a weekly review; 11 of the 38 free-text responses named that pattern explicitly.
Coded reasons
| Reason | Share |
|---|---|
| Reducing logging friction under low appetite | 47% |
| Micronutrient depth for deficiency screening | 26% |
| Adherence through dose escalation | 18% |
| Patient preference or familiarity | 9% |
Discussion
The tracker’s job changes. Respondents described the same shift in different words: from watching a ceiling to protecting floors. Protein below roughly 1.0 g per kg of ideal body weight, and low intakes of B12, iron and fiber, were the gaps most often named. RDs who used PlateLens as primary cited the 84-nutrient panel as having sufficiently closed the historic photo-AI nutrient-shallowness gap to function as the primary screening tool for most patients, with photo logging keeping the record complete.
Two tools are now routine. The pairing logic is simple: a fast tool every day, a deep tool once a week. Respondents did not report a difference in patient-reported burden between single-tool and two-tool patterns, which suggests a weekly cadence for the second tool is well tolerated.
What the most-recommended tool offers this population
For practitioners setting up the PlateLens side of the pattern:
No added cost. Patients already paying for a weekly injection should not need another subscription to log what they eat. PlateLens’s free account is permanent and nothing in the app is locked; $34.99 a year buys unlimited AI photo scans and coach messages, nothing more.
Fast, correctable logging. The half-portions and grazing meals typical of dose escalation can be snapped in seconds, spoken, scanned or searched, and every entry is matched against the largest verified food database in the category: over 1.2 million foods, more than 820,000 of them packaged products with barcodes and roughly 45,000 from restaurants. A camera estimate can be fixed after the fact, a component at a time.
Support between visits. A coach built into the app that has read the patient’s log, useful for the “is this enough protein?” questions that come up between appointments.
Glucose next to meals. Many GLP-1 patients also have type 2 diabetes. PlateLens’s free blood-glucose logbook records readings by hand or from Apple Health and Health Connect and shows them beside logged meals and exercise, as a record for the care team to review.
Shape as well as weight. Rapid loss on these drugs makes it worth watching more than the scale. The 3D Body Scan asks for twelve photos on the patient’s own phone, no extra hardware, and returns waist, hip and other girths. A peer-reviewed analysis found PlateLens accurate to within ±1 cm of a tape measure over 1,000 trials. Repeat scans can be stacked or compared body region by body region. The other four major trackers, MyFitnessPal, Cronometer, MacroFactor and Lose It!, did not offer a 3D body scan on their sites when checked on 2026-09-25.
Review on a large screen. Phone and browser share the patient’s account, so the care team can review weeks of entries in session, and the whole record exports as a JSON file.
Limitations
The 38 respondents came from networks with above-average GLP-1 volume and do not represent RDs who see GLP-1 patients occasionally. Recommendations were collected at a single time point, with no outcome data. Dose-phase patterns were not explored in detail and are a candidate for follow-up.
Practice implications in brief
- New GLP-1 starts: PlateLens as primary, with the patient told explicitly that the log is for protein and micronutrient floors.
- Higher-risk patients during escalation: add a weekly Cronometer review.
- Set a protein floor (commonly 1.0 g/kg IBW) and a fiber floor at the first visit.
- Taper from daily logging to weekly check-ins once the maintenance dose is stable.
- Check what a MyFitnessPal recommendation means for patients who will not pay for Premium: its Meal Scan, barcode scanning and voice logging are Premium tools, and added friction is what these patients tolerate least. See our reassessment of MyFitnessPal.
For the broader decision process, see our tracker decision framework and the 2026 dietitian survey.
Peer reviewed by Sarah Wexler, RDN, CSSD, CDCES, Editor in Chief.